Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in <i>Staphylococcus aureus</i>
Li-Yin Lai, Nidhi Satishkumar, Sasha Cardozo, et al.
Journal of Clinical Pharmacology
|
January 24, 2025
Extended Treatment Duration of Artemether-Lumefantrine in Ugandan Children with HIV on Efavirenz-Based Antiretroviral Therapy: A Randomized Controlled Pharmacokinetic and Pharmacodynamic Trial
Meghan E Whalen, Richard Kajubi, Justin Goodwin, et al.
Open Forum Infectious Diseases
|
December 27, 2016
Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children
Richard Kajubi, Liusheng Huang, Moses Were, et al.
Mbio
|
March 26, 2024
Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in <i>Staphylococcus aureus</i>
Li-Yin Lai, Nidhi Satishkumar, Sasha Cardozo, et al.
Antimicrobial Agents and Chemotherapy
|
November 29, 2021
Loss of GdpP Function in Staphylococcus aureus Leads to β-Lactam Tolerance and Enhanced Evolution of β-Lactam Resistance
Raymond Poon, Li Basuino, Nidhi Satishkumar, et al.
Plos One
|
October 25, 2017
Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children
Liusheng Huang, Vincent Carey, Jane C Lindsey, et al.
Clinical Pharmacology and Therapeutics
|
June 8, 2019
Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention
Meghan E Whalen, Richard Kajubi, Nona Chamankhah, et al.
Communications Biology
|
January 28, 2022
Differential toxicity to murine small and large intestinal epithelium induced by oncology drugs
Jake M Bieber, Laura E Sanman, Xiaoxiao Sun, et al.
JAMA Network Open
|
July 6, 2026
Tamsulosin Deprescribing for Lower Urinary Tract Symptoms in Older Men: A Randomized Clinical Trial
Scott R Bauer, Stacey A Kenfield, Akinyemi Oni-Orisan, et al.
The Journal of Infectious Diseases
|
December 23, 2017
Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz
Erika Wallender, Katarina Vucicevic, Prasanna Jagannathan, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in <i>Staphylococcus aureus</i>
Li-Yin Lai, Nidhi Satishkumar, Sasha Cardozo, et al.
Journal of Clinical Pharmacology
|
January 24, 2025
Extended Treatment Duration of Artemether-Lumefantrine in Ugandan Children with HIV on Efavirenz-Based Antiretroviral Therapy: A Randomized Controlled Pharmacokinetic and Pharmacodynamic Trial
Meghan E Whalen, Richard Kajubi, Justin Goodwin, et al.
Open Forum Infectious Diseases
|
December 27, 2016
Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children
Richard Kajubi, Liusheng Huang, Moses Were, et al.
Mbio
|
March 26, 2024
Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in <i>Staphylococcus aureus</i>
Li-Yin Lai, Nidhi Satishkumar, Sasha Cardozo, et al.
Antimicrobial Agents and Chemotherapy
|
November 29, 2021
Loss of GdpP Function in Staphylococcus aureus Leads to β-Lactam Tolerance and Enhanced Evolution of β-Lactam Resistance
Raymond Poon, Li Basuino, Nidhi Satishkumar, et al.
Plos One
|
October 25, 2017
Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children
Liusheng Huang, Vincent Carey, Jane C Lindsey, et al.
Clinical Pharmacology and Therapeutics
|
June 8, 2019
Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention
Meghan E Whalen, Richard Kajubi, Nona Chamankhah, et al.
Communications Biology
|
January 28, 2022
Differential toxicity to murine small and large intestinal epithelium induced by oncology drugs
Jake M Bieber, Laura E Sanman, Xiaoxiao Sun, et al.
JAMA Network Open
|
July 6, 2026
Tamsulosin Deprescribing for Lower Urinary Tract Symptoms in Older Men: A Randomized Clinical Trial
Scott R Bauer, Stacey A Kenfield, Akinyemi Oni-Orisan, et al.
The Journal of Infectious Diseases
|
December 23, 2017
Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz
Erika Wallender, Katarina Vucicevic, Prasanna Jagannathan, et al.
Page
of 8